Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Children's National Research Institute
- Study ID
- NCT06770010
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 7 Years - 16 Years
- Healthy Volunteers
- Not accepted
Interventions
- Cogmed+ — BEHAVIORALCogmed is a home-based, digital working memory training program compatible with tablet devices. The program, designed for children ages 7 and older, consists of engaging cognitive exercises that target skills involving visuospatial and verbal working memory. An essential component of Cogmed training involves assignment of an intervention "coach" who has access to detailed data on the user's training data. Families will have videoconference meetings once per week with an intervention coach to review progress, provide feedback and answer any questions that arise during treatment. In addition, participants' coaching calls will be supplemented with direct instruction on the use of memory strategies. Social support interventions will also be provided involving three primary approaches: (1) multi-family Cogmed Kickoff social events; (2) social incentives; and (3) peer navigator support.
Study Details
This is a single site nonrandomized pilot clinical trial of the feasibility, acceptability, and efficacy of a combination treatment involving digital Cogmed working memory skills training, social support components, and memory strategy training to improve adherence to Cogmed in youth with sickle cell disease ages 7-16 years.
Key Dates
- Start date
- Mar 5, 2025
- Status verified
- Feb 2025
- Primary completion
- Feb 1, 2026
- Completion
- Apr 1, 2026
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Cogmed+Home-based digital cognitive rehabilitation and memory strategy training targeting working memory functioning.
Primary Outcome Measure
Number of participants who complete Cogmed training [ Time Frame: Approximately 5-8 weeks after start of Cogmed training ]
Central Contacts
- Steven Hardy, PhD202-476-5000
- Sara Ropeta, BS202-476-5000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's National Hospital | Washington D.C. | District of Columbia | 20010 | Steven Hardy, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Washington D.C., DC
By condition
By research site
Related Studies
- Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell DiseasePHASE2 · Recruiting · Robert Nickel · Washington D.C., District of Columbia
- ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruiting · American Thrombosis and Hemostasis Network · Phoenix, Arizona
- Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab StudyPHASE4 · Recruiting · Novartis Pharmaceuticals · Birmingham, Alabama
- Feasibility and Efficacy of Attentional-Control Training in Sickle Cell DiseaseRecruiting · Children's National Research Institute · Washington D.C., District of Columbia